These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22222372)

  • 1. A natural squamosamide derivative FLZ inhibits homocysteine-induced rat brain microvascular endothelial cells dysfunction.
    Kang RX; Zhang JJ
    Biochem Biophys Res Commun; 2012 Jan; 417(4):1176-81. PubMed ID: 22222372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel squamosamide derivative FLZ protects against 6-hydroxydopamine-induced apoptosis through inhibition of related signal transduction in SH-SY5Y cells.
    Zhang D; Zhang JJ; Liu GT
    Eur J Pharmacol; 2007 Apr; 561(1-3):1-6. PubMed ID: 17359966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel squamosamide derivative (compound FLZ) attenuates Abeta25-35-induced toxicity in SH-SY5Y cells.
    Fang F; Liu GT
    Acta Pharmacol Sin; 2008 Feb; 29(2):152-60. PubMed ID: 18215343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamosamide derivative FLZ protects retinal pigment epithelium cells from oxidative stress through activation of epidermal growth factor receptor (EGFR)-AKT signaling.
    Cheng LB; Chen CM; Zhong H; Zhu LJ
    Int J Mol Sci; 2014 Oct; 15(10):18762-75. PubMed ID: 25329617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squamosamide derivative FLZ inhibits TNF-α-induced ICAM-1 expression via down-regulation of the NF-κB signaling pathway in ARPE-19 cells.
    Feng TT; Liang ZY; Chen S
    Int J Clin Exp Pathol; 2015; 8(8):9126-32. PubMed ID: 26464656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of compound FLZ, a novel synthetic analogue of squamosamide, on beta-amyloid-induced rat brain mitochondrial dysfunction in vitro.
    Fang F; Liu GT
    Acta Pharmacol Sin; 2009 May; 30(5):522-9. PubMed ID: 19417731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel squamosamide derivative FLZ enhances BDNF/TrkB/CREB signaling and inhibits neuronal apoptosis in APP/PS1 mice.
    Li N; Liu GT
    Acta Pharmacol Sin; 2010 Mar; 31(3):265-72. PubMed ID: 20154710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel synthetic derivative of squamosamide FLZ inhibits the high mobility group box 1 protein-mediated neuroinflammatory responses in murine BV2 microglial cells.
    Li DC; Bao XQ; Wang XL; Sun H; Zhang D
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):643-650. PubMed ID: 28280849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of S-nitrosohomocysteine.
    Lee SJ; Kim KM; Namkoong S; Kim CK; Kang YC; Lee H; Ha KS; Han JA; Chung HT; Kwon YG; Kim YM
    J Biol Chem; 2005 Feb; 280(7):5781-8. PubMed ID: 15561702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models.
    Tai W; Ye X; Bao X; Zhao B; Wang X; Zhang D
    Neuropharmacology; 2013 Dec; 75():201-12. PubMed ID: 23916477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel cyclic squamosamide analogue compound FLZ improves memory impairment in artificial senescence mice induced by chronic injection of D-galactose and NaNO2.
    Fang F; Liu G
    Basic Clin Pharmacol Toxicol; 2007 Dec; 101(6):447-54. PubMed ID: 17971066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial mechanism of microvascular endothelial cells apoptosis in hyperhomocysteinemia.
    Tyagi N; Ovechkin AV; Lominadze D; Moshal KS; Tyagi SC
    J Cell Biochem; 2006 Aug; 98(5):1150-62. PubMed ID: 16514665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FLZ, a novel HSP27 and HSP70 inducer, protects SH-SY5Y cells from apoptosis caused by MPP(+).
    Kong XC; Zhang D; Qian C; Liu GT; Bao XQ
    Brain Res; 2011 Apr; 1383():99-107. PubMed ID: 21295016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB activation is associated with homocysteine-induced injury in Neuro2a cells.
    Ferlazzo N; Condello S; Currò M; Parisi G; Ientile R; Caccamo D
    BMC Neurosci; 2008 Jul; 9():62. PubMed ID: 18606001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A natural squamosamide derivative FLZ reduces amyloid-beta production by increasing non-amyloidogenic AbetaPP processing.
    Hou Y; Yu YB; Liu G; Luo Y
    J Alzheimers Dis; 2009; 18(1):153-65. PubMed ID: 19625748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physalin A induces apoptosis via p53-Noxa-mediated ROS generation, and autophagy plays a protective role against apoptosis through p38-NF-κB survival pathway in A375-S2 cells.
    He H; Zang LH; Feng YS; Chen LX; Kang N; Tashiro S; Onodera S; Qiu F; Ikejima T
    J Ethnopharmacol; 2013 Jul; 148(2):544-55. PubMed ID: 23684722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models.
    Bao XQ; Kong XC; Qian C; Zhang D
    Neuroscience; 2012 Jan; 202():396-404. PubMed ID: 22138155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel squamosamide derivative (compound FLZ) attenuated 1-methyl, 4-phenyl-pyridinium ion (MPP+)-induced apoptosis and alternations of related signal transduction in SH-SY5Y cells.
    Zhang D; Zhang JJ; Liu GT
    Neuropharmacology; 2007 Feb; 52(2):423-9. PubMed ID: 17055540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamosamide Derivative FLZ Protects Pancreatic β-Cells from Glucotoxicity by Stimulating Akt-FOXO1 Pathway.
    Kong X; Zhang L; Hua X; Ma X
    J Diabetes Res; 2015; 2015():803986. PubMed ID: 26167511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-proliferative effects of the novel squamosamide derivative (FLZ) on HepG2 human hepatoma cells by regulating the cell cycle-related proteins are associated with decreased Ca(2+)/ROS levels.
    Qin Y; Pan X; Tang TT; Zhou L; Gong XG
    Chem Biol Interact; 2011 Sep; 193(3):246-53. PubMed ID: 21835169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.